FGF21 and diabetic kidney disease: It has been shown that the serum FGF21 concentration is significantly increased in patients with diabetic nephropathy, chronic kidney disease, and long-term dialysis (Shahbazi et al., 2015; Li Y.Z. et al., 2018).